Fibrocell Science, Inc.

EXTON, PA How do I update this listing?

Fibrocell Science is based out of Exton. Isolagen Inc. Develops autologous cellular technology with applications in cosmetic dermatology, periodontal disease, reconstructive dentistry and other health-related markets. Specializes in developing this technology for hard and soft tissue regeneration and other therapies.Whalewisdom has at least 90 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-12-20. The notice included securities offered of Equity

Create Alert

Contact Info

fibrocell science, inc.
405 EAGLEVIEW BOULEVARD
EXTON PA    19341

Business Phone: 484-713-6000
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-12-20 D BIOTECHNOLOGY Equity 900,000 900,000 0
2018-07-17 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,064,216 3,064,216 0
2018-06-13 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,087,980 5,087,980 0
2016-08-24 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security 25,000,000 17,625,000 7,375,000
2012-10-15 D BIOTECHNOLOGY Equity 45,000,000 45,000,000 0
2012-05-18 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 12,000,000 3,353,000 8,647,000
2011-08-18 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 22,800,000 22,800,000 0
2011-02-03 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 7,800,000 4,293,000 3,507,000
2010-08-04 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 2,702,000 2,702,000 0
2010-03-29 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 4,880,093 4,880,093 0
2010-03-29 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,807,500 3,807,500 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CHRISTINE ST.CLARE subscription required
    DIRECTOR
DAVID PERNOCK subscription required
    DIRECTOR
DECLAN DALY subscription required
    EXECUTIVE OFFICER DIRECTOR
DOUGLAS J. SWIRSKY subscription required
    DIRECTOR
GEORGE KORKOS subscription required
    DIRECTOR
JOHN MASLOWSKI subscription required
    EXECUTIVE OFFICER
JULIAN KIRK subscription required
    DIRECTOR
KEITH A. GOLDAN subscription required
    EXECUTIVE OFFICER
KELVIN MOORE subscription required
    DIRECTOR
MARC MAZUR subscription required
    DIRECTOR
MARCUS SMITH subscription required
    DIRECTOR
MICHAEL F. MARINO subscription required
    EXECUTIVE OFFICER
PAUL HOPPER subscription required
    DIRECTOR
ROBERT LANGER subscription required
    DIRECTOR
ROBERT LANGOR subscription required
    DIRECTOR
SEAN D. BUCKLEY subscription required
    EXECUTIVE OFFICER

Elevate your investments